Innovation

V2 Vasopressin Antagonists (Technology#: 091405-01)

Lehigh University Office of Technology Transfer
posted on 07/10/2009

Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V.sub.1a receptor ##STR00001##
 
Applications
*Treatment of diseased mammals
 
Status of Intellectual Property
This technology is protected under US Patent 7,268,125
 


Innovation Details
 

File Number: 091405-01 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Yatin Karpe at Lehigh University Office of Technology Transfer for more information.

request more info
People

Case Manager:

Icon_avatar Yatin Karpe

Innovations (57)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

4,059 members 12,270 innovations 109 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...